# Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection

> **NCT02206789** · NA · UNKNOWN · sponsor: **Aravind Eye Care System** · enrollment: 200 (estimated)

## Conditions studied

- Corneal Graft Rejection

## Interventions

- **DRUG:** Prednisolone acetate1%,
- **DRUG:** Prednisolone acetate1%, cyclosporine 2%

## Key facts

- **NCT ID:** NCT02206789
- **Lead sponsor:** Aravind Eye Care System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2017-02
- **Final completion:** 2017-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2014-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02206789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02206789, "Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02206789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*